vs
Side-by-side financial comparison of Coda Octopus Group, Inc. (CODA) and FENNEC PHARMACEUTICALS INC. (FENC). Click either name above to swap in a different company.
FENNEC PHARMACEUTICALS INC. is the larger business by last-quarter revenue ($13.8M vs $7.3M, roughly 1.9× Coda Octopus Group, Inc.). Coda Octopus Group, Inc. runs the higher net margin — 14.1% vs -34.7%, a 48.8% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 43.8%). Over the past eight quarters, Coda Octopus Group, Inc.'s revenue compounded faster (27.7% CAGR vs -26.3%).
CODA plc was a mid-sized international financial software company based in the United Kingdom. Founded in 1979, it was purchased in 2008 by Unit4, a supplier of enterprise software, based in the Netherlands. CODA creates, markets and implements a range of business software systems designed for finance directors and finance departments. These include:financial management systems like accounting software and procurement software: financial analysis applications like reporting, consolidation and...
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
CODA vs FENC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.3M | $13.8M |
| Net Profit | $1.0M | $-4.8M |
| Gross Margin | 67.6% | — |
| Operating Margin | 19.3% | -18.5% |
| Net Margin | 14.1% | -34.7% |
| Revenue YoY | 43.8% | 73.8% |
| Net Profit YoY | 214.3% | -141.1% |
| EPS (diluted) | $0.10 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.3M | $13.8M | ||
| Q3 25 | $7.1M | $12.5M | ||
| Q2 25 | $7.0M | $9.7M | ||
| Q1 25 | $5.2M | $8.8M | ||
| Q4 24 | $5.1M | $7.9M | ||
| Q3 24 | $5.5M | $7.0M | ||
| Q2 24 | $5.3M | $7.3M | ||
| Q1 24 | $4.5M | $25.4M |
| Q4 25 | $1.0M | $-4.8M | ||
| Q3 25 | $1.3M | $-638.0K | ||
| Q2 25 | $908.8K | $-3.2M | ||
| Q1 25 | $913.0K | $-1.2M | ||
| Q4 24 | $326.2K | $-2.0M | ||
| Q3 24 | $1.3M | $-5.7M | ||
| Q2 24 | $1.4M | $-5.6M | ||
| Q1 24 | $629.9K | $12.8M |
| Q4 25 | 67.6% | — | ||
| Q3 25 | 68.3% | — | ||
| Q2 25 | 64.1% | — | ||
| Q1 25 | 65.8% | — | ||
| Q4 24 | 65.3% | — | ||
| Q3 24 | 73.9% | — | ||
| Q2 24 | 70.2% | — | ||
| Q1 24 | 69.2% | — |
| Q4 25 | 19.3% | -18.5% | ||
| Q3 25 | 19.5% | -1.5% | ||
| Q2 25 | 15.5% | -28.3% | ||
| Q1 25 | 12.7% | -9.2% | ||
| Q4 24 | 5.7% | -11.8% | ||
| Q3 24 | 25.4% | -74.6% | ||
| Q2 24 | 25.4% | -69.4% | ||
| Q1 24 | 12.4% | 54.2% |
| Q4 25 | 14.1% | -34.7% | ||
| Q3 25 | 18.2% | -5.1% | ||
| Q2 25 | 13.0% | -32.7% | ||
| Q1 25 | 17.5% | -13.3% | ||
| Q4 24 | 6.5% | -25.0% | ||
| Q3 24 | 23.3% | -82.2% | ||
| Q2 24 | 26.6% | -76.5% | ||
| Q1 24 | 14.1% | 50.6% |
| Q4 25 | $0.10 | $-0.17 | ||
| Q3 25 | $0.11 | $-0.02 | ||
| Q2 25 | $0.08 | $-0.11 | ||
| Q1 25 | $0.08 | $-0.04 | ||
| Q4 24 | $0.02 | $-0.02 | ||
| Q3 24 | $0.11 | $-0.21 | ||
| Q2 24 | $0.13 | $-0.20 | ||
| Q1 24 | $0.06 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $28.7M | $36.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $58.1M | $35.5M |
| Total Assets | $64.5M | $70.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.7M | $36.8M | ||
| Q3 25 | $26.2M | $21.9M | ||
| Q2 25 | $24.5M | $18.7M | ||
| Q1 25 | $22.5M | $22.7M | ||
| Q4 24 | $22.5M | $26.6M | ||
| Q3 24 | $25.2M | $40.3M | ||
| Q2 24 | $23.7M | $43.1M | ||
| Q1 24 | $25.0M | $51.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $19.4M | ||
| Q2 25 | — | $19.4M | ||
| Q1 25 | — | $19.4M | ||
| Q4 24 | — | $19.3M | ||
| Q3 24 | — | $32.1M | ||
| Q2 24 | — | $31.8M | ||
| Q1 24 | — | $31.3M |
| Q4 25 | $58.1M | $35.5M | ||
| Q3 25 | $57.3M | $-4.5M | ||
| Q2 25 | $55.9M | $-7.5M | ||
| Q1 25 | $53.1M | $-5.9M | ||
| Q4 24 | $53.1M | $-5.9M | ||
| Q3 24 | $52.8M | $-5.2M | ||
| Q2 24 | $51.1M | $-1.4M | ||
| Q1 24 | $50.1M | $3.0M |
| Q4 25 | $64.5M | $70.6M | ||
| Q3 25 | $61.9M | $49.3M | ||
| Q2 25 | $60.6M | $44.9M | ||
| Q1 25 | $56.9M | $46.4M | ||
| Q4 24 | $57.5M | $44.9M | ||
| Q3 24 | $55.9M | $58.9M | ||
| Q2 24 | $54.0M | $63.2M | ||
| Q1 24 | $53.0M | $69.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9M | $-6.0M |
| Free Cash FlowOCF − Capex | $2.5M | — |
| FCF MarginFCF / Revenue | 34.9% | — |
| Capex IntensityCapex / Revenue | 5.0% | — |
| Cash ConversionOCF / Net Profit | 2.83× | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9M | $-6.0M | ||
| Q3 25 | $2.2M | $1.5M | ||
| Q2 25 | $1.5M | $-3.7M | ||
| Q1 25 | $641.5K | $-4.3M | ||
| Q4 24 | $2.0M | $-1.5M | ||
| Q3 24 | $1.7M | $-2.2M | ||
| Q2 24 | $-955.8K | $-8.4M | ||
| Q1 24 | $-298.0K | $39.0M |
| Q4 25 | $2.5M | — | ||
| Q3 25 | $1.6M | — | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $513.4K | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $-1.1M | — | ||
| Q1 24 | $-433.6K | — |
| Q4 25 | 34.9% | — | ||
| Q3 25 | 22.6% | — | ||
| Q2 25 | 19.9% | — | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 38.5% | — | ||
| Q3 24 | 28.2% | — | ||
| Q2 24 | -20.9% | — | ||
| Q1 24 | -9.7% | — |
| Q4 25 | 5.0% | — | ||
| Q3 25 | 8.6% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 2.9% | — | ||
| Q1 24 | 3.0% | — |
| Q4 25 | 2.83× | — | ||
| Q3 25 | 1.72× | — | ||
| Q2 25 | 1.61× | — | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 6.11× | — | ||
| Q3 24 | 1.34× | — | ||
| Q2 24 | -0.68× | — | ||
| Q1 24 | -0.47× | 3.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CODA
| Segment Reporting | $3.1M | 42% |
| Transferred At Point In Time | $1.8M | 24% |
| Precision Acoustics Limited | $1.3M | 18% |
| Other | $1.1M | 15% |
FENC
Segment breakdown not available.
